RecruitingPhase 4

A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis

China140 participantsStarted 2020-02-01

Plain-language summary

The investigators are trying to determine if oral Probiotics(Umeta-mimi,30 days) with Metronidazole vaginal suppositories (7 days) is better than using Metronidazole vaginal suppositories(7 days) only in preventing the recurrence of bacterial vaginosis

Who can participate

Age range18 Years – 55 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Aged 18 to 55 years old, with history of sexual activity,
✓. Amsel criterion for diagnosing BV
✓. Sign informed consent

Exclusion criteria

✕. History of systemic organic diseases or psychiatric diseases
✕. Planning for or during pregnancy, lactation, menstruation
✕. within 5 days of onset of the disease, any antibiotics has been used
✕. Long-term use of contraceptives or immunosuppressant
✕. Anaphylactic constitution or allergic to known ingredients of research drugs
✕. No same fixed partner (RSP) before and after treatment

What they're measuring

Cure rate of BV

Timeframe: 14 days after treatment

Trial details

NCT IDNCT04771728

SponsorPeking University Shenzhen Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-01

Contact for this trial

Shangrong Fan, M.D.

86-755-83923333 fanshangrong@163.com

View on ClinicalTrials.gov More Bacterial Vaginosis trials